Skip to main content
Premium Trial:

Request an Annual Quote

RainDance, Harvard Share Grant to Develop Cell Sorter

NEW YORK (GenomeWeb News) – RainDance Technologies today said that it and a Harvard researcher will share a $750,000 grant from The Massachusetts Life Sciences Center to develop a new fluorescence-activated cell sorter.
 
The Lexington, Mass.-based firm said that the MLSC awarded a grant of $250,000 per year for three years to the firm and David Weitz, a physics professor in Harvard’s school of engineering and applied sciences and physics department. The partners plan to develop and demonstrate the use of a new form of the cell sorter that incorporates RainDance’s RainStorm micro-droplet technology.
 
Raindance was one of six projects to receive funding totaling $3.7 million from the MLSC. The awards will be matched dollar-for-dollar by the industry partners involved with each collaboration.
 
Chris McNary, president and CEO of RainDance, noted that the latest project expands the initial applications for the RainStorm technology, which thus far has been applied to targeted genomic resequencing as well as high-throughput screening and small molecule storage for the drug discovery market.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.